ADAMTS13 and thrombotic microangiopathy: Additional studies have expanded the clinical application of ADAMTS13 testing beyond thrombotic microangiopathies into liver diseases, as reduced ADAMTS13 levels directly correlate with the progression and severity of liver cirrhosis.